COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Newton PN., Bond KC., Adeyeye M., Antignac M., Ashenef A., Awab GR., Babar Z-U-D., Bannenberg WJ., Bond KC., Bower J., Breman J., Brock A., Caillet C., Coyne P., Day N., Deats M., Douidy K., Doyle K., Dujardin C., Ejekam CS., Fernández F., Freifeld C., Gill M., Guerin PJ., Harigwo G., Heide L., Horby P., Kaur H., Kayumba PC., Kazuko K., Kelly C., Khuluza F., Kigera S., Lalani M., Lamy M., Lieberman M., Lumpkin M., Mackey T., Naughton B., Newton PN., Nguyen P., Olliaro P., Ozawa S., Patel A., Phanouvong S., Pisani E., Pyzik O., Rägo L., Rahman MS., Ranjit E., Ravinetto R., Richmond D., Singh-Phulgenda S., Venema J., Vogt A., White N., Wirtz VJ., Zaman M.

DOI

10.1016/s2214-109x(20)30136-4

Type

Journal article

Journal

The Lancet Global Health

Publisher

Elsevier BV

Publication Date

06/2020

Volume

8

Pages

e754 - e755

Permalink Original publication